Clinical Trial Update: GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial in treatment-experienced adults with chronic genotype 1 hepatitis C tested a regimen including GS-5885, GS-9451, Tegobuvir, and ribavirin; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-5885 (GS-5885)
• GS-9451 (GS-9451)
• Ribavirin (ribavirin)
• Tegobuvir (Tegobuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED